Hopp til innhold
NHI.no
Annonse

Hudkreft (basalcellekreft): Diagnostikk av basalcellekreft

Innhold i artikkelen

Hudens utseende og sykehistorien vil gi legen mistanke om diagnosen. For å bekrefte mistanken, vil legen selv ta en hudprøve eller sende pasienten videre til hudlege eller kirurg. Hudprøven sendes så inn til mikroskopisk undersøkelse.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Basalcellekarsinom . Referanselisten for dette dokumentet vises nedenfor

  1. Bader RS. Basal cell carcinoma. Medscape, last updated Sep 15, 2015.
  2. Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ 2003; 327: 974-8. PubMed
  3. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146:283. PubMed
  4. Diepgen TL, Mahler VM. The epidemiology of skin cancer. Br J Dermatol 2002;146(suppl 61): 1-6.
  5. Sterry W; European Dermatology Forum Guideline Committee. Guidelines: the management of basal cell carcinoma. Eur J Dermatol. 2006;16:467-475. PubMed
  6. Stulberg DL, Crandell B, Fawcett RS. Diagnosis and treatment of basal cell and squamous cell carcinomas. Am Fam Physician 2004; 70: 1481-8. PubMed
  7. Sellheyer K. Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers. Br J Dermatol 2011; 164: 696-711. PubMed
  8. Schwartz RA. Basal cell carcinoma. BMJ Best Practice, last updated Aug 22, 2016. bestpractice.bmj.com
  9. Corona R, Dogliotti E, D'Errico M, Sera F, Iavarone I, Baliva G, et al. Risk factors for basal cell carcinoma in a Mediterranean population. Arch Dermatol 2002;137: 1162-8. PubMed
  10. Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88:167-79. pmid:26029015 PubMed
  11. Wehner MR, Shive ML,l Chren M-M. Indoor tanning and non-melanoma skin cancer: a systematic review and meta-analysis. BMJ 2012; 345: e5909. BMJ (DOI)
  12. Gjersvik P, Helsing P, Holdaas H, Bergan S. Immunsuppressive legemidler og utvikling av hudkreft etter organtransplantasjon. Tidsskr Nor Legeforen 2012; 132: 2064-8. Tidsskrift for Den norske legeforening
  13. Nikanjam M,Cohen PR,Kato S,Sicklick JK,Kurzrock R, Advanced Basal Cell Cancer: Concise Review of Molecular Characteristics and Novel Targeted and Immune Therapeutics. Annals of oncology : official journal of the European Society for Medical Oncology. 2018. PMID: 30219896 PubMed
  14. Gullestad HP. Oncolex: Om non-melanom hudkreft. Kirurgi - sist revidert 2011.
  15. Brownell I. Nodular basal cell carcinoma: when in doubt, cut it out. J Drugs Dermatol. 2007 Dec. 6(12):1245-6.
  16. Helsing P, Kramer P, Haugstvedt Å, et al. Kirurgisk behandling av basalcellekarsinomer. Tidsskr Nor Lægeforen 2004; 124: 2740-2. PubMed
  17. Tindholdt TT, Tønseth KA, Bjærke TK, Åbyholm, FE. Fotodynamisk terapi av basalcellekarsinom i ansiktet. Tidsskr Nor Lægeforen 2007; 127: 1928-30. PubMed
  18. Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Fox TL, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicentre 6-week dose-response trial. J Am Acad Dermatol 2001;44: 807-13. PubMed
  19. Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722-33. PubMed
  20. Karve SJ, Feldman SR, Yentzer BA, et al. Imiquimod: a review of basal cell carcinoma treatments. J Drugs Dermatol 2008; 7: 1044-51. PubMed
  21. Telfer NR, Colver GB, Morton CA. British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48. PubMed
  22. Tang JY, Mackay-Wiggan JM, Aszterbaum M et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012; 366: 2180 – 8
  23. Mc Loone NM, Tolland J, Walsh M, et al. Follow-up of basal cell carcinomas: an audit of current practice. J Eur Acad Dermatol Venereol. Jul 2006. 20(6):698-701.
  24. Cho M, Gordon L, Rembielak A, et al. Utility of radiotherapy for treatment of basal cell carcinoma: a review. Br J Dermatol. 2014 Nov;171(5):968-73. doi: 10.1111/bjd.13253 DOI
  25. Sánchez G, Nova J, Rodriguez-Hernandez AE, et al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database Syst Rev. 2016 Jul 25;7:CD011161. pmid: 27455163 PubMed
  26. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 2015; doi: 10.1056/NEJMoa1506197 DOI
  27. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer. Arch Dermatol 2000;136: 1524-30. PubMed
  28. Morgan FC, Ruiz ES, Karia PS et al. Factors Predictive of Recurrence, Metastasis, and Death from Primary Basal Cell Carcinoma 2cm or Larger in Diameter. J Am Acad Dermatol 2019. S0190-9622(19)32824-5. pmid:31600531 PubMed
  29. Karagas MR, Stukel TA, Greenberg ER, et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA 1992; 267: 3305-10. Journal of the American Medical Association
Annonse
Annonse